International Medical Director – Urgo Medical (APAC, Middle East and South Africa), United Arab Emirates
Special Issue Article
The Explorer study â?? How has it affected the international view of diabetic foot ulcer management?
Author(s): Emilio Galea
The Explorer Study, published on the Lancet in March 2018, was a high level double blind RCT that showed that the use of sucrose octusalfate can reduce healing time of neuro-ischemic DFUs by 60 days. Previous studies also portrayed reduction in healing time for other chronic wounds such as VLUs and PIs with TLC-NOSF.
During this presentation we will give a very brief overview of the study but moreover show how the international community has reacted to these results. Recently the IWGDG has included TLC-NOSF in their guidelines and NICE (UK) has recommended the use of this modality for all chronic wound patients in the UK. This has also been taken on board by D-Foot International in their DFU referral pathway and over 100 protocols in Europe include the same in their recommendations.
The presentation will also include advice on how to implement a 3 tier progra.. View More»